BiomX to Present Part 1 Data from Phase 1b/2a Study Evaluating BX004 for the Treatment of Chronic Pseudomonas aeruginosa Pulmonary Infections in Patients with Cystic Fibrosis During Late-Breaking Science Session at the 46th European Cystic Fibrosis Conference (ECFC)
CAMBRIDGE, Mass. and NESS ZIONA, Israel, May 31, 2023 (GLOBE NEWSWIRE) — BiomX Inc. (NYSE…
OKSPOT Unveils Privacy-Focused Crypto Exchange for Global Traders With No-KYC Registration and Monero Support
Mambu and Mastercard expand cross-border payment capabilities for banks across APAC
Indonesia’s ITS Celebrates 66th Anniversary and Officially Closes KSTI 2026
Shaping the Future Together: Voices from Around the World at the III International Symposium ‘Creating the Future’ in Russia
The UAE’s AI Adoption Is a World Record. Paying for It Is Another Story